glp 1 trial GLP-1 Drug Pipeline 2026 Daily Oral GLP-1 Receptor Agonist

Not approved by FDA, EMA or as of 2026

The use of GLP-1 receptor agonists for weight loss is still relatively new, and there isnt much data on how to help patients manage the weight gain that typically happens aYer the cessation of medication

By the end of the first week, many patients begin to tolerate the medication better, and the side effects often diminish

Note: Some GLP-1s are not approved for weight loss, but some doctors may prescribe them off-label for this use

The global G-protein coupled receptors market size is calculated at US$ 3.86 in 2024, grew to US$ 4.06 billion in 2025, and is projected to reach around US$ 6.37 billion by 2034

Poor sleep is rarely just a lifestyle inconvenience